2IHU image
Entry Detail
PDB ID:
2IHU
Keywords:
Title:
Carboxyethylarginine synthase from Streptomyces clavuligerus: putative reaction intermediate complex
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2006-09-27
Release Date:
2007-11-27
Method Details:
Experimental Method:
Resolution:
2.05 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Carboxyethylarginine synthase
Chain IDs:A, B, C, D
Chain Length:573
Number of Molecules:4
Biological Source:Streptomyces clavuligerus
Primary Citation
Structural and mechanistic studies on N(2)-(2-carboxyethyl)arginine synthase.
Biochem.Biophys.Res.Commun. 385 512 517 (2009)
PMID: 19477162 DOI: 10.1016/j.bbrc.2009.05.095

Abstact

N(2)-(2-Carboxyethyl)arginine synthase (CEAS), an unusual thiamin diphosphate (ThDP)-dependent enzyme, catalyses the committed step in the biosynthesis of the b-lactamase inhibitor clavulanic acid in Streptomyces clavuligerus. Crystal structures of tetrameric CEAS-ThDP in complex with the substrate analogues 5-guanidinovaleric acid (GVA) and tartrate, and a structure reflecting a possible enol(ate)-ThDP reaction intermediate are described. The structures suggest overlapping binding sites for the substrates D-glyceraldehyde-3-phosphate (D-G3P) and L-arginine, and are consistent with the proposed CEAS mechanism in which D-G3P binds at the active site and reacts to form an alpha,beta-unsaturated intermediate,which subsequently undergoes (1,4)-Michael addition with the alpha-amino group of L-arginine. Additional solution studies are presented which probe the amino acid substrate tolerance of CEAS, providing further insight into the L-arginine binding site. These findings may facilitate the engineering of CEAS towards the synthesis of alternative beta-amino acid products.

Legend

Protein

Chemical

Disease

Primary Citation of related structures